A Kuwabara1, N Tsugawa2, K Tanaka3, Y Uejima1, J Ogawa1, N Otao1, N Yamada1, T Masaki4, C Nishigori4, S Moriwaki5, T Okano2. 1. Department of Health and Nutrition, Osaka Shoin Women's University, Higashiosaka-shi, Osaka, Japan. 2. Department of Hygienic Sciences, Kobe Pharmaceutical University, Kobe, Japan. 3. Department of Food and Nutrition, Kyoto Women's University, Kyoto, Japan. 4. Department of Dermatology, Clinical Molecular Medicine, Graduate School of Medicine, Kobe University, Kobe, Japan. 5. Department of Dermatology, Osaka Medical College, Osaka, Japan.
Abstract
BACKGROUND/ OBJECTIVES: Xeroderma pigmentosum (XP) is a rare autosomal recessive disease characterized by defective repair of ultraviolet (UV) irradiation-induced DNA damage and high risk of skin cancer. Thus, these patients require strict photoprotection. Considering the importance of UV-mediated cutaneous vitamin D production, such rigorous photoprotection would cause vitamin D deficiency. Then, we have studied the vitamin D status in patients with XP-A, a group requiring the most strict photoprotection. SUBJECTS/ METHODS: Twenty-one patients with XP-A (aged 6-25) were evaluated for their vitamin D intake, serum levels of 25-hydroxy-vitamin D (25OHD) and parathyroid hormone (PTH). Vitamin D intake was assessed by a 2-day food weighing method. RESULTS: Median dietary intake of vitamin D was 4.1 μg/day, and the median concentrations of serum 25OHD and PTH were 7.7 and 49.9 pg/ml, respectively. In 76% of the patients, serum 25OHD level was lower than 10 ng/ml, indicating vitamin D deficiency. Vitamin D intake and serum 25OHD level were significantly lower in patients under enteral nutrition (EN) than those with oral intake (OI). Multivariate analyses revealed that EN was a significant predictor of decreased serum 25OHD level (β coefficient=-0.59, P=0.03). CONCLUSIONS: Vitamin D deficiency is highly prevalent in XP-A patients, and supplementation should be considered to avoid unfavorable skeletal consequences in these patients. In addition, determination of dietary vitamin D requirement has been a difficult work issue in the decision of dietary reference intakes (DRIs) because of its cutaneous production. Data from XP patients would yield useful information for the determination of DRIs for vitamin D.
BACKGROUND/ OBJECTIVES:Xeroderma pigmentosum (XP) is a rare autosomal recessive disease characterized by defective repair of ultraviolet (UV) irradiation-induced DNA damage and high risk of skin cancer. Thus, these patients require strict photoprotection. Considering the importance of UV-mediated cutaneous vitamin D production, such rigorous photoprotection would cause vitamin D deficiency. Then, we have studied the vitamin D status in patients with XP-A, a group requiring the most strict photoprotection. SUBJECTS/ METHODS: Twenty-one patients with XP-A (aged 6-25) were evaluated for their vitamin D intake, serum levels of 25-hydroxy-vitamin D (25OHD) and parathyroid hormone (PTH). Vitamin D intake was assessed by a 2-day food weighing method. RESULTS: Median dietary intake of vitamin D was 4.1 μg/day, and the median concentrations of serum 25OHD and PTH were 7.7 and 49.9 pg/ml, respectively. In 76% of the patients, serum 25OHD level was lower than 10 ng/ml, indicating vitamin D deficiency. Vitamin D intake and serum 25OHD level were significantly lower in patients under enteral nutrition (EN) than those with oral intake (OI). Multivariate analyses revealed that EN was a significant predictor of decreased serum 25OHD level (β coefficient=-0.59, P=0.03). CONCLUSIONS:Vitamin D deficiency is highly prevalent in XP-A patients, and supplementation should be considered to avoid unfavorable skeletal consequences in these patients. In addition, determination of dietary vitamin D requirement has been a difficult work issue in the decision of dietary reference intakes (DRIs) because of its cutaneous production. Data from XP patients would yield useful information for the determination of DRIs for vitamin D.
Authors: Yuko Hirai; Yoshiaki Kodama; Shin-Ichi Moriwaki; Asao Noda; Harry M Cullings; Donald G Macphee; Kazunori Kodama; Kiyohiko Mabuchi; Kenneth H Kraemer; Charles E Land; Nori Nakamura Journal: Mutat Res Date: 2006-08-14 Impact factor: 2.433
Authors: Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer Journal: J Med Genet Date: 2010-11-19 Impact factor: 6.318
Authors: Sofia Nessvi; Lisa Johansson; Jan Jopson; Alistair Stewart; Anthony Reeder; Richard McKenzie; Robert K Scragg Journal: Photochem Photobiol Date: 2011-07-28 Impact factor: 3.421
Authors: Laura K DeLong; Sarah Wetherington; Nikki Hill; Meena Kumari; Bryan Gammon; Scott Dunbar; Vin Tangpricha; Suephy C Chen Journal: Semin Cutan Med Surg Date: 2010-09
Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver Journal: J Clin Endocrinol Metab Date: 2011-06-06 Impact factor: 5.958
Authors: Pawel Pludowski; Michael F Holick; Stefan Pilz; Carol L Wagner; Bruce W Hollis; William B Grant; Yehuda Shoenfeld; Elisabeth Lerchbaum; David J Llewellyn; Katharina Kienreich; Maya Soni Journal: Autoimmun Rev Date: 2013-03-28 Impact factor: 9.754
Authors: N Yoshimura; S Muraki; H Oka; M Morita; H Yamada; S Tanaka; H Kawaguchi; K Nakamura; T Akune Journal: Osteoporos Int Date: 2013-05-15 Impact factor: 4.507
Authors: T Passeron; R Bouillon; V Callender; T Cestari; T L Diepgen; A C Green; J C van der Pols; B A Bernard; F Ly; F Bernerd; L Marrot; M Nielsen; M Verschoore; N G Jablonski; A R Young Journal: Br J Dermatol Date: 2019-07-15 Impact factor: 9.302
Authors: Mahlatse C M Kgokolo; Katherine Anderson; Shalate C Siwele; Helen C Steel; Luyanda L I Kwofie; Mike M Sathekge; Pieter W A Meyer; Bernardo L Rapoport; Ronald Anderson Journal: Front Oncol Date: 2022-02-11 Impact factor: 6.244